Bicycle Therapeutics (BCYC) Change in Receivables (2018 - 2025)

Bicycle Therapeutics (BCYC) has 7 years of Change in Receivables data on file, last reported at $133000.0 in Q1 2025.

• Quarterly Change in Receivables changed N/A year-over-year to $133000.0 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $170000.0 (changed N/A YoY) and the FY2023 annual result came in at -$2.5 million, down 251.25% from the prior year.
• Change in Receivables fell to $133000.0 in Q1 2025, from $49.9 million in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $49.9 million in Q3 2023 to a low of -$49.8 million in Q2 2023.
• A 4-year average of -$477363.6 and a median of -$991000.0 in 2022 frame the typical range for Change in Receivables.
• The widest YoY moves for Change in Receivables: up 614.5% in 2023, down 582.14% in 2023.
• Tracing BCYC's Change in Receivables over 4 years: stood at $1.0 million in 2021, then surged by 98.7% to $2.0 million in 2022, then jumped by 2407.59% to $49.9 million in 2023, then slumped by 99.73% to $133000.0 in 2025.
• The last three Change in Receivables figures came in at $133000.0 (Q1 2025), $49.9 million (Q3 2023), and -$49.8 million (Q2 2023), per Business Quant data.